Introduction to the SCID Mouse NK Efficacy Model of InnoModels Biotechnology
- Categories:Company news
- Author:InnoModels
- Origin:InnoModels
- Time of issue:2024-08-27 15:57
- Views:
(Summary description)The SCID mouse is a mouse model with an autosomal recessive purist Prkdcscid mutant that causes mice to exhibit severe combined immunodeficiency.SCID mice lack mature T and B lymphocytes but retain some functions of macrophages and NK cells. This model is uniquely advantageous in the efficacy assessment of NK cell-associated drugs because NK cells can function independently in the absence of interference from other immune cells
Introduction to the SCID Mouse NK Efficacy Model of InnoModels Biotechnology
(Summary description)The SCID mouse is a mouse model with an autosomal recessive purist Prkdcscid mutant that causes mice to exhibit severe combined immunodeficiency.SCID mice lack mature T and B lymphocytes but retain some functions of macrophages and NK cells. This model is uniquely advantageous in the efficacy assessment of NK cell-associated drugs because NK cells can function independently in the absence of interference from other immune cells
- Categories:Company news
- Author:InnoModels
- Origin:InnoModels
- Time of issue:2024-08-27 15:57
- Views:
Introduction
With the rapid development of biomedicine, especially the continuous progress in the field of immunotherapy, it is especially important to find efficient and reliable experimental models to verify drug efficacy. InnoModels Biotechnology (Beijing) Co., Ltd. has made remarkable breakthroughs in the field of immunotherapy, especially in natural killer (NK) cell immunotherapy. The company has successfully developed an NK efficacy model based on SCID (Severe Combined Immunodeficiency) mice, which provides strong support for the development of NK cell-related drugs.
Overview of the SCID mouse model
The SCID mouse is a mouse model with an autosomal recessive purist Prkdcscid mutant that causes mice to exhibit severe combined immunodeficiency.SCID mice lack mature T and B lymphocytes but retain some functions of macrophages and NK cells. This model is uniquely advantageous in the efficacy assessment of NK cell-associated drugs because NK cells can function independently in the absence of interference from other immune cells.
Advantages of the InnoModels SCID Mouse NK Efficacy Model
1. High homology
Mouse NK cells are highly homologous to human NK cells in terms of their development, functional properties and acquisition of memory-like features. Therefore, the SCID mouse model has high accuracy in simulating human NK cell responses, providing a solid foundation for preclinical evaluation of NK cell immunotherapy drugs.
2. Efficient NK cell reconstitution
By optimizing the experimental conditions, InnoModels Biotechnology has successfully achieved efficient NK cell reconstitution in SCID mice. This not only improves the sensitivity of drug evaluation, but also makes the pharmacodynamic response closer to the actual clinical situation.
3. Stable pharmacodynamic response
The SCID mouse model shows high stability during drug evaluation and can accurately reflect the effects of different drugs on NK cells. In addition, the model can also conveniently predict the efficacy of different donors, the degree of matching with tumor cells, and their ability to trigger graft-versus-host disease (GVHD), thus improving the reliability and reproducibility of the experimental results.
Model Application and Experimental Procedure
Applications
The SCID mouse NK efficacy model is widely used in the preclinical evaluation of NK cell-related drugs, including immune checkpoint inhibitors, NK cell activators, and ADCC drugs targeting tumor-specific targets. In addition, the model can also be used to validate the efficacy of innovative therapies such as CAR-NK cell therapy.
Experimental Procedure
1. **Model preparation**: select healthy SCID mice as experimental subjects, and ensure that the mice do not have other immunodeficiencies or diseases.
2. **NK Cell Reconstruction**: Through specific experimental methods, NK cells are reconstructed in the mice to reach a certain number and activity level.
3. **Drug administration**: mice are injected with the NK cell-related drug to be evaluated according to the experimental design.
4. **Drug Efficacy Assessment**: At different time points after drug administration, blood and tissue samples of mice are collected to detect changes in the number, activity and function of NK cells, and to assess the growth of tumor cells at the same time.
5. **DATA ANALYSIS**: Based on the experimental results, analyze the effect of the drug on NK cells and its anti-tumor effect, and provide data support for further development of the drug.
Conclusion
The SCID mouse NK efficacy model successfully developed by InnoModels Biotechnology provides a reliable platform for preclinical evaluation of NK cell immunotherapy drugs. The model not only has the advantages of high homology, efficient NK cell reconstitution and stable pharmacodynamic response, but also is widely used in the development of many NK cell-related drugs. With the deepening of the research, it is believed that the model will play an even more important role in the future and promote the further development of the immunotherapy field.
- Tel 15010000264
- E-mail limy@imodels.tech
- Tel 13810723384
- Top
InnoModels Biotechnology (Beijing) Co., Ltd.
TEL:15010000264 13810723384
Email:cndw@imodels.tec
Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing
Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company